Pregled bibliografske jedinice broj: 1253573
Pentadecapeptide BPC 157 Shortens Duration of Tetracaine- and Oxybuprocaine-Induced Corneal Anesthesia in Rats
Pentadecapeptide BPC 157 Shortens Duration of Tetracaine- and Oxybuprocaine-Induced Corneal Anesthesia in Rats // Acta clinica Croatica, 59 (2020), 394-406 doi:10.20471/acc.2020.59.03.02 (recenziran, članak, znanstveni)
CROSBI ID: 1253573 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pentadecapeptide BPC 157 Shortens Duration of
Tetracaine- and Oxybuprocaine-Induced Corneal
Anesthesia in Rats
Autori
Mirković, Ivan ; Kralj, Tamara ; Lozić, Marin ; Stambolija, Vasilije ; Kovačević, Josip ; Vrdoljak, Luka ; Zlatar, Mirna ; Milanović, Kristina ; Drmić, Domagoj ; Predović, Jurica ; Masnec, Sanja ; Jurjević, Matija ; Bušić, Mladen ; Seiwerth, Sven ; Kokot, Antonio ; Sikirić, Predrag
Izvornik
Acta clinica Croatica (0353-9466) 59
(2020);
394-406
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BPC 157 ; corneal anesthesia ; NOS ; oxybuprocaine ; rats ; tetracaine
Sažetak
We focused on the relationship of 0.5% tetracaine- and 0.4% oxybuprocaine-induced corneal anesthesia in rats, and pentadecapeptide BPC 157 (0.4 µg/eye), along with nitric oxide synthase (NOS) inhibitor N(gamma)-nitro-L-arginine methyl ester (L-NAME) (0.1 mg/eye) and/or NOS substrate L- arginine (2 mg/eye), applied in the form of eye drops. We assessed corneal sensitivity recovery (Cochet-Bonnet esthesiometer), corneal lesion elimination (staining with 10% fluorescein) and decrease in tear volume (Schirmer test). BPC 157 administration had a full counteracting effect. Recovery also occurred in the presence of NOS blockade and NOS substrate application. L-arginine eventually shortened duration of corneal insensitivity and exerted corneal lesion counteraction (and counteraction of tetracaine- induced decrease of tear volume) only in earlier but not in later period. L-NAME application led to longer duration of corneal insensitivity, increase in corneal lesions and decrease in tear volume. When L-NAME and L-arginine were applied together, they antagonized each other's effect. These distinctions may indicate particular NOS involvement (corneal insensitivity vs. corneal lesion along with tear production), distinctively affected by the administration of NO agents. However, additional BPC 157 co-administration would re-establish counteraction over topical ophthalmic anesthetic-induced effect, be it in its early or late course. We suggest BPC 157 as an antidote to topical ophthalmic anesthetics.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Stomatološki fakultet, Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
Klinički bolnički centar Zagreb,
Medicinski fakultet, Osijek
Profili:
Marin Lozić
(autor)
Mladen Bušić
(autor)
Antonio Kokot
(autor)
Sven Seiwerth
(autor)
Josip Kovačević
(autor)
SANJA MASNEC
(autor)
Jurica Predović
(autor)
Ivan Mirković
(autor)
Predrag Sikirić
(autor)
Kristina Milanović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE